Milestone Scientific Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.1M | $-839.9K | $-1.1M | $-1.2M | $-1.5M | $-2.0M | $-2.0M | $-1.5M |
| Depreciation & Amortization | $19.6K | $19.5K | $19.2K | $20.1K | $19.5K | $19.4K | $8.7K | $8.6K |
| Depreciation | $2.5K | $2.4K | $2.2K | $2.6K | $2.0K | $2.0K | $1.9K | $1.7K |
| Amortization | $17.1K | $17.1K | $17.0K | $17.5K | $17.5K | $17.5K | $6.9K | $6.9K |
| Stock-Based Compensation | $309.6K | $256.7K | $99.2K | $363.1K | $159.7K | $330.8K | $339.9K | $484.1K |
| Net Cash from Operating Activities | $-585.1K | $86.8K | $-226.1K | $81.8K | $-1.8M | $-1.0M | $-1.5M | $-973.9K |
| Investing Activities | ||||||||
| Capital Expenditures | $4.1K | $1.6K | $3.1K | $6.2K | $4.5K | $1.3K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-4.1K | $-1.6K | $-3.1K | $-6.2K | $-4.5K | $-1.3K | $-3.5K | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.5M | $-3.4K | $-3.4K | $-4.6K | $796.6K | $-2.3K | $-2.5K | $-2.6K |
| Net Change in Cash | $872.3K | $81.8K | $-232.7K | $71.0K | $-972.1K | $-1.0M | $-1.5M | $-976.5K |
| Free Cash Flow | $-589.3K | $85.2K | $-229.2K | $75.5K | $-1.8M | $-1.0M | — | — |